S. Tries
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacological Effects of Natural Compounds 5
- Inflammatory mediators and NSAID effects 3
-
- Chemical synthesis and pharmacological studies 2
- Synthesis and Biological Evaluation 2
- Co-authors
- Stefan Laufer (14 shared papers)Johanne Martel-Pelletier (1 shared paper)Dragan Jovanović (1 shared paper)Julio Fernandes (1 shared paper)Pascal Reboul (1 shared paper)John Lawrence Wallace (1 shared paper)W. McKnight (1 shared paper)William M. Abraham (1 shared paper)
In The Last Decade
S. Tries
16 papers receiving 456 citations
Peers
Comparison fields: 5 of 59
- Pharmacology 274
- Pharmacology 97
- Biochemistry 78
- Rheumatology 85
- Toxicology 17
Countries citing papers authored by S. Tries
This map shows the geographic impact of S. Tries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Tries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Tries more than expected).
Fields of papers citing papers by S. Tries
This network shows the impact of papers produced by S. Tries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Tries. The network helps show where S. Tries may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Tries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 95 | |
| 2 | 2002 | 86 | |
| 3 | 2001 | 61 | |
| 4 | 1994 | 40 | |
| 5 | Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors. | 2002 | 37 |
| 6 | Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis. | 2001 | 31 |
| 7 | Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid. | 1995 | 25 |
| 8 | 1997 | 23 | |
| 9 | 1997 | 21 | |
| 10 | Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophenyl-7-phenyl- 2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat. | 1994 | 17 |
| 11 | General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals. | 1995 | 16 |
| 12 | 2002 | 13 | |
| 13 | Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors | 2002 | 5 |
| 14 | Studies on the in vitro and in vivo genotoxicity of [2,2-dimethyl-6- (4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid. | 1995 | 5 |
| 15 | 2001 | 4 | |
| 16 | 1991 | 2 |
About S. Tries
S. Tries is a scholar working on Pharmacology, Pharmacology, Organic Chemistry, Toxicology and Molecular Biology, having authored 16 papers that have together received 481 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (5 papers), Plant Toxicity and Pharmacological Properties (4 papers), Inflammatory mediators and NSAID effects (3 papers), Chemical synthesis and pharmacological studies (2 papers), Synthesis and Biological Evaluation (2 papers), Cancer therapeutics and mechanisms (2 papers), Lipoproteins and Cardiovascular Health (1 paper) and Respiratory and Cough-Related Research (1 paper). The work is most often cited by research in Pharmacology (274 citations), Pharmacology (97 citations), Biochemistry (78 citations), Rheumatology (85 citations) and Toxicology (17 citations). S. Tries has collaborated with scholars based in Germany, Canada and Japan. Frequent co-authors include Stefan Laufer, Johanne Martel-Pelletier, Dragan Jovanović, Julio Fernandes, Pascal Reboul, John Lawrence Wallace, W. McKnight, William M. Abraham, Florina Moldovan and Michel Neidhart. Their work appears in journals such as Inflammation Research, Inflammopharmacology, Archiv der Pharmazie, European Journal of Pharmacology and Pulmonary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.